findmyKOL
Clinical trialNCT07552181Not, yet, recruitingPhase 2Interventional

Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer

SponsorYuan YuanEnrollment50Early Stage Triple-Negative Breast CarcinomaTNBCTNBC - Triple-Negative Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Cedars-Sinai Medical Center Beverly Hills

    Beverly Hills, California, United States

    Karissa Britten, MDMaryliza El-Masry, MDPhilomena McAndrew, MDYuan Yuan, MD
  • Cs Cancer at Valley Oncology Medical Group

    Tarzana, California, United States

    Mazen Jizzini, MDNatasha Banerjee, MDRyan Ponec, MD
  • Hunt Cancer Institute, An Affiliate of Cs Cancer

    Torrance, California, United States

    Andrew Horodner, MDDavid Chan, MDHugo Hool, MDJustin Tiulim, MDSwati Skiaria, MDSyed Jilani, MDThomas Lowe, MDVanessa Dickey, MD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2026
Primary completion
30 Sept 2035
Completion
30 Sept 2035
Last update posted
24 Jun 2026
Registered enrollment
50
Registry id
NCT07552181
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.